Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -526.75x is 294% below its 5-year average of -133.67x, around the middle of its 5-year range (-1496.00x–1.96x).
22.44% above its 12-month average of -679.17x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -1496.00x.
INTEREST COVERAGE RATIO
-526.75x
INTEREST COVERAGE RATIO AVG TTM
-679.17x
INTEREST COVERAGE RATIO AVG 3Y
-351.49x
INTEREST COVERAGE RATIO AVG 5Y
-133.67x
INTEREST COVERAGE RATIO AVG 10Y
-17.64x
INTEREST COVERAGE RATIO AVG 15Y
-30.37x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+22.44%
CURRENT VS 3Y AVG
-49.86%
CURRENT VS 5Y AVG
-294.06%
CURRENT VS 10Y AVG
-2885.66%
CURRENT VS 15Y AVG
-1634.17%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-8079.35%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.38M
Interest Coverage Ratio
-526.75x
TTM Avg
-679.17x
3Y Avg
-351.49x
5Y Avg
-133.67x
Market Cap
$23.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.13M
Interest Coverage Ratio
-5.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.44M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.60M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$22.00M
Interest Coverage Ratio
4.39x
TTM Avg
4.39x
3Y Avg
4.39x
5Y Avg
4.39x
Market Cap
$25.22M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.38M | -526.75x | -679.17x | -351.49x | -133.67x |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.68M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | -5.24x | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | N/A | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR)vs › | $24.60M | N/A | 1.00x | 1.00x | 1.00x |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 4.39x | 4.39x | 4.39x | 4.39x |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | -17.20x | 55.75x | 55.75x | 55.75x |
| NextCure, Inc. (NXTC)vs › | $20.53M | N/A | N/A | N/A | N/A |
Interest Coverage
-526.8x
Debt/Equity
0.20
Current Ratio
3.22
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -1496.00x |
| 2025-09-30 | -276.67x |
| 2025-06-30 | -347.50x |
| 2025-03-31 | -596.50x |
| 2024-09-30 | -378.00x |
| 2024-06-30 | -557.80x |
| 2023-12-31 | -18.95x |
| 2023-09-30 | -88.65x |
| 2023-06-30 | -54.93x |
| 2023-03-31 | -53.34x |
| 2022-12-31 | 1.96x |
| 2022-09-30 | -6.45x |
| 2022-06-30 | -3.94x |
| 2022-03-31 | -1.24x |
| 2021-12-31 | -4.67x |
| 2021-09-30 | -7.41x |
| 2021-06-30 | -4.63x |
| 2021-03-31 | -2.86x |
| 2020-12-31 | -4.55x |
| 2020-09-30 | -3.25x |
| 2020-06-30 | -6.41x |
| 2020-03-31 | -8.13x |
| 2019-12-31 | -7.84x |
| 2019-09-30 | -4.84x |
| 2019-06-30 | -10.34x |
| 2019-03-31 | -18.23x |
| 2018-12-31 | -18.21x |
| 2018-09-30 | -16.74x |
| 2018-06-30 | -62.14x |
| 2014-03-31 | -34.42x |
| 2013-12-31 | -20.23x |
| 2013-09-30 | -16.16x |
| 2013-06-30 | -14.18x |
| 2012-12-31 | -3.21x |
| 2012-06-30 | -42.84x |
| 2012-03-31 | -28.13x |
| 2011-12-31 | -116.26x |
| 2011-09-30 | -123.10x |
| 2011-06-30 | -302.83x |
| 2011-03-31 | -198.06x |
| 2010-09-30 | -1.04x |
| 2010-06-30 | -7.85x |
| 2010-03-31 | -15.24x |
| 2009-12-31 | -113.31x |
| 2009-09-30 | -167.47x |
